Cleared Traditional

K871722 - MEDTENS(TM)

K871722 is the FDA 510(k) clearance for MEDTENS(TM) by Medtronic Vascular. It is a Class 2 Neurology device (product code GZJ) cleared through the Traditional 510(k) pathway after a 78-day FDA review.

K871722 · Medtronic Vascular · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1987
Decision
78d
Days
Class 2
Risk

K871722 is an FDA 510(k) clearance for the MEDTENS(TM), MODEL NUMBER 7725. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Medtronic Vascular (Minneapolis, US). The FDA issued a Cleared decision on July 21, 1987 after a review of 78 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medtronic Vascular devices

Submission Details

510(k) Number K871722 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 04, 1987
Decision Date July 21, 1987
Days to Decision 78 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 148d · This submission: 78d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 116
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K871722.
MEDIPAC II EC (TM), MODEL 7900
K882820 · Medical Devices, Inc. · Aug 1988
EMPI MODEL 989, TENS
K881114 · Empi · Apr 1988
ULTRAPAC II SX PLUS (TM)
K872657 · Medical Devices, Inc. · Aug 1987
ELECTRO-NERVE STIMULATOR TENS MODEL B5/SKN
K871125 · Biomedical Life Systems, Inc. · Jun 1987
ELECTRO-NERVE STIMULATOR TENS MODEL C & B11, B11C
K871126 · Biomedical Life Systems, Inc. · Jun 1987
OMEGA T100
K870666 · Henley Intl. · Apr 1987